This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Texas A&M University System. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations in Cardiac Repair: The Contributions of RyangHwa Lee
Introduction
RyangHwa Lee is an accomplished inventor based in Round, Texas. He has made significant contributions to the field of regenerative medicine, particularly in the area of cardiac repair. His innovative work focuses on the use of mesenchymal stem cells to address cardiac tissue damage and inflammatory diseases.
Latest Patents
RyangHwa Lee holds a patent for "Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage." This invention provides compositions comprising mesenchymal stem cells (MSCs) and outlines methods for their novel use in repairing cardiac damage. The invention also highlights the use of TSG-6 protein, secreted by MSCs under specific conditions, for the repair of cardiac damage and treatment of inflammatory diseases. The compositions are particularly useful in restoring cardiac function following damage, such as myocardial infarction, and in alleviating symptoms of inflammatory diseases.
Career Highlights
RyangHwa Lee is affiliated with The Texas A&M University System, where he continues to advance research in stem cell therapy and cardiac repair. His work has garnered attention for its potential to improve patient outcomes in cardiovascular health.
Collaborations
RyangHwa Lee collaborates with Darwin J Prockop, a notable figure in the field of stem cell research. Their partnership enhances the impact of their research and contributes to the advancement of innovative therapies.
Conclusion
RyangHwa Lee's contributions to the field of cardiac repair through his innovative use of mesenchymal stem cells represent a significant advancement in regenerative medicine. His work has the potential to transform treatment options for patients suffering from cardiac damage and inflammatory diseases.